saturated barium hydroxide. Each sample was centrifuged and filtered, and strated to be involved in the activation of NNK in animal and 0.2 ml was coinjected with 5 µl of NNK metabolite standards onto a human tissue microsomes (5, 6, 11, 12, 18) . P450s 1A2, 2A1, reverse-phase HPLC system equipped with a radioflow detector (Radiomatic and/or 2B1 are responsible for the oxidation of NNK in rat Instruments and Chemical Co., Tampa, FL) (5). The HPLC conditions used and mouse lung microsomes (6,7). In rat liver microsomes, were the same as previously described (18) .
For kinetic studies, NNK concentrations of 1, 5, 10, 20, 50, 100, 200, 500, P450s 1A2, 2A1, and 3A account for only a fraction of the and 1000 µM were used in incubations. For inhibition studies, air or a mixture activity of NNK oxidation (18) . Our studies have suggested of carbon monoxide and air (9:1) was bubbled through the microsome-buffer that P450 2A6 or a P450 2A6-related enzyme is involved in mixture for 3 min before using in incubations or the chemical inhibitors were the activation of NNK in human lung microsomes (12). In dissolved in methanol and used at 0.5% of the total incubation volume. At this concentration, methanol had no effect on NNK metabolism. When TAO human liver microsomes, P450s 1A2, 2A6, 2E1, and 3A4 have was used, the microsomes were preincubated with 1 mM NADPH and 50 µM been shown to be responsible for NNK activation (11, 19) .
TAO for 30 min at 37°C. The reaction was then initiated with NNK and 1
Using expressed human P450s, it has been demonstrated that mM NADPH.
P450s 1A2, 2A6, 2B7, 2D6, 2E1, 2F1, 3A4, and 3A5 catalyzed
Coumarin metabolism analysis the α-hydroxylation of NNK (11, 19, 20) . Of these expressed
Coumarin 7-hydroxylation was determined as described (25) . In brief, incubaP450s, P450s 1A2 and 2A6 showed the lowest K m values tions contained 50 mM TrisϪHCl (pH 7.4), 1 mM NADPH, 50 µM coumarin, (118-309 µM) in the formation of 4-oxo-1-(3-pyridyl)-1-and 0.05 mg (liver) or 0.2 mg (lung) microsomal protein in a total volume of butanone (keto aldehyde) and 4-hydroxy-1-(3-pyridyl)-1-but-0.5 ml. Reactions were carried out for 15 min at 37°C. Samples were extracted, centrifuged and the formation of 7-hydroxycoumarin was measured by anone (keto alcohol) (α-hydroxylation products) (11, 19 were compared with our previous results in humans and rodents.
Results

Materials and methods
NNK metabolism Chemicals
In the patas monkey lung microsomes, the formation of 
Kinetic parameters
Organs were rapidly removed and immediately chilled prior to preparation of For lung and liver microsomes, 7 and 9 concentrations of microsomes by differential centrifugation followed by washing and resuspen-NNK (1-1000 µM) were used, respectively, to determine the sion in 0.25 M sucrose (23) . Microsomes were stored at Ϫ80°C. The protein kinetic parameters in the activation of NNK. Michaelis-Menten concentration was determined according to Lowry et al. (24) , using bovine serum albumin as the standard.
kinetics were observed in the formation of keto aldehyde, NNK-N-oxide, and keto alcohol in the patas monkey lung and
NNK metabolism analysis
liver microsomes when NNK concentration ranges of 1-20
Unless otherwise stated, incubations consisted of 100 mM sodium phosphate (pH 7.4), 1 mM EDTA, 3 mM MgCl 2 , an NADPH-generating system (5 mM µM (lung) and 1-50 µM (liver) were used ( Figure 2A and B).
glucose 6-phosphate, 1 mM NADPϩ, and 1.5 units glucose 6-phosphate
The apparent K m and V max values are summarized in Table I. dehydrogenase), 10 µM NNK (containing 1 µCi [5-3 H]NNK), 5 mM sodium
In the patas monkey lung microsomes, the apparent K m for bisulfite, and 0.1 mg (liver) or 0.2 mg (lung) microsomal protein in a total the formation of keto aldehyde (10.3 µM) was 2-fold higher volume of 0.4 ml. Reactions were carried out for 20 min (liver) or 30 min (lung) at 37°C and terminated with 100 µl each of 25% zinc sulfate and than the K m for keto alcohol (4.9 µM). The apparent K m for the formation of NNK-N-oxide (5.4 µM) was similar to the K m for keto alcohol. The formation of NNAL, possibly due to the activity of carbonyl reductase, however, displayed a very large K m (902 µM). In the patas monkey liver microsomes, the apparent K m (8.1 µM) and V max (37 pmol/min/mg protein) values were the same in the formation of keto aldehyde and keto alcohol, suggesting that the same enzyme may be involved in the formation of both metabolites. In addition to the low K m enzymes, other enzymes are involved in the formation of keto aldehyde, NNK-N-oxide and keto alcohol in the patas monkey lung and liver microsomes because saturation kinetics for the formation of these metabolites were not observed in the NNK concentration range of 100-1000 µM (data not shown). were used (Tables II and III ). In the patas monkey lung microsomes, the rate of formation of keto aldehyde, NNK-Noxide, keto alcohol, and NNAL was decreased by carbon monoxide by 48, 61, 66, and 38%, respectively. Aspirin, a cyclooxygenase inhibitor, decreased keto alcohol formation by 10%. NDGA, a lipoxygenase inhibitor, decreased the formation of keto aldehyde and keto alcohol by 20 and 15%, respectively. Preincubation of the microsomes in the absence of NADPH, which was intended for the inactivation of the flavin-containing monooxygenase, decreased the formation of NNK-N-oxide and keto alcohol by 12 and 8%, respectively (Table II) . In the patas monkey liver microsomes, carbon monoxide decreased the rate of formation of keto aldehyde, keto alcohol, and NNAL by 89, 91, and 82%, respectively. Aspirin, NDGA, and preincubation had no significant effects on NNK metabolism in monkey liver microsomes (Table III) . The results suggest that P450 plays a major role in the metabolism of NNK in the patas monkey liver microsomes, whereas in the patas monkey lung microsomes, P450 is only partially involved in NNK metabolism.
Effect of inhibitors on NNK metabolism
To determine the P450 forms that are involved in the activation of NNK in the patas monkey lung and liver microsomes, various chemical inhibitors were used. α-Napthoflavone, coumarin and TAO are selective inhibitors of P450s 1A, 2A6, and 3A in human liver microsomes (26) (27) (28) , respectively. In monkey lung microsomes, α-napthoflavone and coumarin decreased the oxidation of NNK by 11-33% and 10-40%, respectively (Figure 3) . In monkey liver microsomes, α-napthoflavone significantly inhibited the formation of keto alcohol by 43%. Coumarin decreased the rate of formation of keto aldehyde and keto alcohol by~60% (Figure 3) . TAO had no appreciable effects on NNK metabolism in monkey lung and liver microsomes. The results suggest that P450s 1A and 2A6 may be involved in the oxidation of NNK in the patas monkey lung and liver microsomes.
To investigate the involvement of P450 2A6 in the oxidation of NNK in the patas monkey lung and liver microsomes, a The antibody had no effect on NNK-N-oxide and NNAL (r) and keto alcohol (d) was determined. Points are the mean of two formation. In liver microsomes, the formation of keto aldehyde replicates; the difference between replicates was Ͻ10%.
and keto alcohol was decreased by 22% and 24%, respectively (Table IV) . 
a The kinetic parameters for keto aldehyde, NNK-N-oxide, and keto alcohol formation in patas monkey lung and liver microsomes were determined using four and five concentrations of NNK, respectively. For NNAL formation, seven and nine concentrations of NNK were used in patas monkey lung and liver microsomes, respectively. Values are the mean Ϯ SD of two replicates. b ND, metabolite was not detectable. metabolism of NNK in the patas monkey lung and liver microc The microsome-buffer mixture was preincubated at 37°C for 10 min in the somes, NNK was used as an inhibitor of coumarin metabolism.
absence of NADPH.
As the NNK concentration increased, the formation of 7-hydroxycoumarin decreased (Figure 4) . However, the percent decrease Hepatic microsomal P450s 1A and 2A6 in 7-hydroxycoumarin formation by NNK was less (by 50%) Since the above results suggest that P450s 1A and 2A6 are than that observed when coumarin was used as an inhibitor of involved in the oxidation of NNK, P450s 1A and 2A in the liver NNK metabolism in the lung and liver microsomes (Figure 3) . microsomes of the patas monkey were determined by immunoThese results suggest that coumarin may be oxidized by other blot analysis using anti-rat P450 1A and anti-human P450 2A6 P450(s), in addition to P450 2A6, in the patas monkey lung and liver microsomes. antibodies. The intensities of the protein bands are shown in 
Inhibition of NNK metabolism by PEITC
PEITC, a compound derived from cruciferous vegetables, has been shown to be an effective inhibitor of NNK metabolism in rodent lung microsomes and human lung and liver microsomes by inhibiting P450s (5,7,12,31). In the patas monkey lung and liver microsomal incubations, the inhibition of NNK oxidation by PEITC was concentration-dependent ( Figure 5 ). In the patas monkey lung microsomes, the estimated IC 50 values for keto aldehyde, NNK-N-oxide, and keto alcohol formation were 0.80, 0.30, and 0.28 µM, respectively. In liver microsomes, the estimated IC 50 values for keto aldehyde and keto alcohol formation were 6.8 and 4.2 µM, respectively. The formation of NNAL by the lung and liver microsomes was not affected by PEITC at all concentrations. microsomes (5,7). In contrast, carbonyl reduction of NNK (NNAL formation) has been observed to be the major pathway in human lung microsomes (11, 12) and cultured human lung hydroxylation rate for NNK was greater with the monkey lung and liver microsomes than human lung and liver microsomes. explants (13) . Furthermore, the formation of keto alcohol was observed in the patas monkey (Figure 1) and rodent lung This quantitative difference may reflect the level of P450s which are present in the microsomes. microsomes (6,7), but not in human lung microsomes (11, 12) . These differences in the metabolic profile for human and patas
The presence of low K m forms of enzymes for NNK oxidation were observed in the patas monkey lung and liver monkey lung microsomes may be due to differences in the amount of P450s or in the regiospecificity of metabolism by microsomes (Table I and Figure 2 ). This result is in contrast to the high K m values (400-1200 µM) observed in human lung these enzymes. The metabolic profile for NNK in patas monkey, human and rodent liver microsomes are similar in that NNAL and liver microsomes (11, 19) . Of the expressed human P450s studied, P450 2A6 exhibited the lowest K m value (118 µM) is the major metabolite formed (11, 18) . However, the α- (Tables II   three determinations. and III). A general P450 inhibitor, metyrapone (100 µM), also decreased NNAL formation in the monkey lung and liver microsomes by 43 and 83%, respectively (data not shown). (19) . It is possible that other enzymes are important in the low K m pathway for NNK oxidation in humans.
Carbon monoxide has also been demonstrated to inhibit the rate of NNAL formation in human lung microsomes (by 5-P450 enzymes are known to be responsible for the metabolism of many carcinogens. Similar to the results obtained with 38%), depending on the particular sample examined (12). Our results suggest that P450 may be involved in the formation of human and rat liver microsomes (11, 18) , P450s are the major enzymes involved in the metabolism of NNK in patas monkey NNAL in the patas monkey and humans. It is also possible that carbon monoxide may be inhibiting other enzymes in liver microsomes (Table III) . In contrast, P450s were only partially involved in NNK metabolism in the patas monkey lung addition to P450. Further studies are needed to establish the enzymes that catalyze NNAL formation in these species. microsomes (Table II) , analagous to human lung microsomes (11, 12) . The use of chemical inhibitors suggests that lipoxygenPrevious studies with human lung and liver microsomes suggested that the activation of NNK is catalyzed by P450s ase and cyclooxygenase also play a role in the activation of NNK in the patas monkey lung microsomes. Similar results 1A2, 2A6, 2E1 and/or 3A4 (11, 12, 19) . P450s 1A and 2A6 appeared to be involved in the oxidation of NNK in the patas have been observed with human lung microsomes (12), but not rodent lung microsomes (5,6). In liver microsomes, P450s monkey lung and liver microsomes based on the inhibitory action of α-napthoflavone, coumarin, and an anti-2A6 antibody exist at rather high levels and will apparently have a predominant role in NNK metabolism in the species studied. On the on NNK metabolism (Figure 3 and Table IV) , and the inhibition of coumarin metabolism (a representative activity for P450 other hand, in patas monkey and human lung microsomes, the levels of P450s are low and other enzymes such as lipoxygenase 2A6) by NNK (Figure 4 ). α-Napthoflavone is an inhibitor of P450s 1A1 and 1A2 (26) . It has been demonstrated that P450 and cyclooxygenase may also contribute to the activation of NNK.
1A2, but not P450 1A1 is present in the patas monkey liver microsomes (32) . Therefore, α-napthoflavone is most likely It has been postulated that carbonyl reductase is responsible for the formation of NNAL (1). Surprisingly, carbon monoxide inhibiting P450 1A2 in the patas monkey liver microsomes. Studies have shown that P450 1A2 is responsible for the decreased the formation of NNAL in the patas monkey lung formation of keto alcohol in human liver microsomes (11, 31) . more, the involvement of P450s 1A and 2A in the activation of NNK in the patas monkey lung and liver microsomes is The inhibition of only keto alcohol formation by α-napthoflavone in the patas monkey liver microsomes is consistent similar to that in humans. with the involvement of P450 1A2 in the formation of this metabolite. Immunoblotting experiments demonstrated that the Acknowledgement P450 2A level was~6-fold greater in the patas monkey This study was supported by NIH grant CA46535 and NIEHS Center liver microsomal sample than in an individual human liver Grant ES05022. microsomal sample (Table V) . This result for P450 2A is similar to our coumarin metabolism results in which the References activity was 5-fold higher in the patas monkey liver microsomal 
